麻豆淫院

OnKure, a privately-held biopharmaceutical company developing best-in-class, targeted oncology therapeutics, announced that it has raised $55 million in a Series B financing. Proceeds will be used to advance the Company鈥檚 next generation histone deacetylase (HDAC) inhibitors further into clinical development and fund a growing pipeline of earlier stage molecules.

Distinguished Engineering Professor Christopher Bowman, who is a serial inventor working with Venture Partners, has been elected to the National Academy of Engineering, one of the highest professional distinctions accorded to engineers. Bowman was chosen for his innovations related to photopolymerization, a process that uses light to trigger reactions that form new polymers. These polymers are used for an array of medical and technological applications, such as 3D printing, dental fillings, medical devices and augmented reality displays.

It鈥檚 hard to imagine a teenager who could resist exploring mechanical engineering after learning about Endoculus, the small device developed by CU Boulder Professor Mark Rentschler that can navigate the human gastrointestinal system with ease and may someday help doctors care for their patients. Futurum helped translate Rentschler鈥檚 complex research into easy-to-digest (no pun intended) content that teachers can incorporate into their lesson plans and share with their students.

The National Academy of Inventors (NAI) today announced that CU Boulder researchers and spinout founders Mark Rentschler, Greg Rieker and Tin Tin Su have been designated as NAI Senior Members in recognition of their impact on society through extraordinary innovation.

Register now to attend the biggest Destination Startup庐 yet, from February 16-18, 2021. Twenty-five startups from 10 different universities across six states in the Rocky Mountain region will showcase their technologies, drawing investors from around the world.

Dipika Singh got her first taste of commercialization in 2012鈥�13 when she and her supervisor at the University of Nebraska Medical Center developed a proprietary medium for freezing neurons. At the time of her invention, Singh was 25 and deciding whether to pursue a PhD or explore the business side of biotech. She earned an MBA at the University of Colorado Boulder. While there, she did an internship at the university鈥檚 tech transfer office. Seven years later she is a senior licensing officer at the university.

Arpeggio Bio is a therapeutics company that is developing cancer treatments. They share how they used their own technology to do drug discovery, and sold it as 鈥渃onsulting鈥� to build credibility with investors and trust with a few initial clients.

In a statement, the Boulder company said the additional funds were part of a second close of its Series A round this year, bringing its total fundraising haul to the year to $214 million in both cash and non-cash funding. SomaLogic is developing blood-testing platforms to measure for thousands of proteins in a patient鈥檚 blood or urine sample that may signal current illnesses or risks for developing a future health condition.

As we wind down for the holidays, the Venture Partners team wants to celebrate the accomplishments of our resilient community of world-class innovators, business partners and dedicated mentors. We鈥檙e excited to share our highlights of this year.

From February 16-18, 2021, Venture Partners will host the biggest Destination Startup庐 yet, showcasing 26 startups from 10 different universities across six states in the Rocky Mountain region鈥攏ot just Colorado鈥攁nd drawing investors from around the world. Registration is now open!